Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ziprasidone adjunctive maintenance in Bipolar I Disorder
2005-004167-27Phase 3Completed
- Sponsor
- Pfizer
- Start
- Dec 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in bipolar I disorder comparing Zeldox plus mood stabilizer with Placebo plus mood stabilizer (2 arms). Primary endpoint: Time to intervention for a mood episode. Started Dec 2005; status: completed.
02
Drugs
ziprasidone
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on 2005-004167-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004167-27.